Summary
Arne Bruyneel is a corporate strategy and M&A leader at Grünenthal with eight years of experience bridging biomedical research and commercial strategy in the pharmaceutical and life sciences sector. He holds a DPhil from Oxford, completed a Stanford postdoc and Stanford Ignite program, and earned an INSEAD MBA with distinction, pairing deep scientific expertise with rigorous business training. Having lived, worked or studied across Europe, Singapore and the U.S., he brings a truly international lens to deal-making and portfolio strategy. His background in bioscience engineering, cell and gene biotechnology and statistical data analysis gives him rare technical fluency when evaluating R&D assets and translational risk. Known for synthesizing complex scientific narratives into commercial decisions, he excels at aligning scientific promise with realistic commercialization pathways.
8 years of coding experience
High School, Latin-Mathematics, High School, Latin-Mathematics at Don Bosco Zwijnaarde
Doctor of Philosophy (Ph.D.), Physiology, Anatomy and Genetics, Doctor of Philosophy (Ph.D.), Physiology, Anatomy and Genetics at University of Oxford
Master of Business Administration - MBA, Distinction, Master of Business Administration - MBA, Distinction at INSEAD
Stanford Ignite, Certificate Program in Innovation and Entrepreneurship, Stanford Ignite, Certificate Program in Innovation and Entrepreneurship at Stanford University Graduate School of Business
Master of Science - MS, Statistical Data Analysis, Master of Science - MS, Statistical Data Analysis at Ghent University
Biotechnology, Biotechnology at University of Helsinki
English, Dutch, French, German, Swedish